Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they live
19 employees · est. 2019 · Philadelphia, United States
Tubulis GmbH is the larger of the two.
Side-by-Side Comparison
| Metric | Interius BioTherapeutics | Tubulis GmbH |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2019 |
| Headquarters | ||
| Headquarters | Philadelphia, United States | Germany |
| Employees | ||
| Employees | 19 | 119 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Acquired |
| Total Funding | ||
| Total Funding | $504.43M | $3.66B |
| Funding Rounds | ||
| Funding Rounds | 6 | 11 |
| Services | ||
| Services | Development of Genetic Medicines, Engineering of Targeted Vectors, Clinical Trials for Therapeutics, Research and Development in Oncology, Development of Autoimmunity Treatments | ADC Development, Clinical Research, Biophysical Property Analysis |
| Target Customers | ||
| Target Customers | Patients with Challenging Diseases, Healthcare Providers, Medical Researchers, Biotechnology Investors, Pharmaceutical Companies | Pharmaceutical Companies, Medical Researchers, Oncologists, Cancer Patients |
| Taxonomy | ||
| Taxonomy | In Vivo Gene Therapy, Cell Engineering, B Cell Lymphomas Treatment, Intravenous CAR Treatment, Target Tissue Specificity, Autoimmune Conditions Therapy, Gene Medicines, Biopharmaceuticals, Cell-specific Therapy, Precision Medicine, Therapy Without Chemotherapy, Expanded Care Settings | Antibody Drug Conjugates, Targeted Therapy, Drug Development, Chemotherapy Alternatives, Cancer Treatment, Protein-Drug Conjugates, Disease-Specific Biology, Pharmaceuticals, Chronic Disorder Treatment, Innovative Technology, Oncology |
| Website | ||
| Website | interiusbio.com | tubulis.com |
About Interius BioTherapeutics
Interius BioTherapeutics is at the forefront of transforming cell engineering by developing innovative techniques to modify cells directly within the human body, as captured in their slogan: "Interius is developing new ways to engineer cells inside the human body, right where they live." Founded in...
About Tubulis GmbH
Tubulis GmbH, with its slogan "Reimagining ADCs.", represents a significant stride in the biotechnology space. Founded in 2019, the company quickly positioned itself at the intersection of Biotechnology, Health Care, Health and Wellness, Life Sciences, and Pharmaceutical sectors. Its headquarter is...
We will tell you when either one moves
BounceWatch watches Interius BioTherapeutics and Tubulis GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Interius BioTherapeuti... and Tubulis GmbH — by email.
Frequently Asked Questions
Compare Interius BioTherapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Interius BioTherapeutics on 15 Jun 2026, and Tubulis GmbH on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.